An antral follicle count (AFC), sometimes called a basal antral follicle count, is an early-cycle ultrasound measurement of the small follicles visible in your ovaries. It helps your physician estimate your ovarian reserve and understand how your ovaries may respond to fertility medications.
At Illume Fertility, AFC is typically completed during a baseline transvaginal ultrasound. Your physician will interpret the result alongside your age, AMH level, Cycle Day 3 blood work, medical history, and other fertility testing.
Schedule Your Consult Download Testing WorkbookWhat to know before your appointment.
The number of small, resting follicles visible in the ovaries, which helps estimate ovarian reserve.
Typically performed during an early-cycle baseline ultrasound on Cycle Days 2–5.
A brief transvaginal ultrasound with mild pressure and no recovery time.
An immediate verbal summary, with a written report generally available in 1–2 days.
Disclaimer: This content is provided for educational purposes only. It should not be used to diagnose or treat any condition. Always consult your healthcare provider for personalized medical guidance.
An antral follicle is a small, fluid-filled sac that contains an immature egg. Each month, a group of follicles begins developing, with the potential for one to become dominant and release an egg during ovulation.
During an AFC ultrasound, your provider counts the visible resting follicles in both ovaries. The total number is known as your antral follicle count.
During an early-cycle ultrasound, the provider performing your ultrasound will count the small follicles measuring approximately 2–10 mm in both ovaries.
As your cycle progresses, some follicles grow larger and one may become dominant, but those larger developing follicles are not included in your initial baseline AFC.
An antral follicle count is completed during a baseline transvaginal ultrasound. You will lie on an exam table and remain covered with a drape while a thin, gel-coated ultrasound probe is gently inserted a few inches into the vagina.
You may also request to insert the probe yourself with guidance from your provider, if this helps you feel more comfortable.
The probe creates clear, real-time images of both ovaries so your provider can count the small resting follicles. During the scan, your provider will also evaluate ovarian health, uterine lining, and pelvic anatomy for cysts or other findings that may need further evaluation.
Most patients feel mild pressure or discomfort rather than pain. You can return to your normal activities immediately after the exam.
Explore Transvaginal Ultrasound
Internal ultrasounds can feel difficult for many reasons, including pelvic pain, anxiety, dysphoria, or past trauma. Ask your provider to slow down, reposition the probe, pause, or stop at any time. You don't need to disclose personal details you would rather keep private.
Note: We welcome you to bring up any preferences or accommodations before the exam.
Ovarian reserve refers to the estimated number of eggs remaining in the ovaries. AFC provides a direct view of the small follicles available at the beginning of a menstrual cycle.
Your physician may use this information to better understand your ovarian reserve and anticipate how your ovaries could respond to fertility medications.
AFC can help predict ovarian response and potential egg yield, but it does not provide an exact egg count or determine your likelihood of pregnancy on its own.
There is no universally accepted "normal" antral follicle count.
In general, a count below approximately 3–6 follicles may raise concern about diminished ovarian reserve, but your age, hormone levels, medical history, and other test results all affect how the finding is interpreted.
AFC results provide valuable information, but they are only one part of a complete fertility evaluation. Ovarian reserve testing is more useful for predicting the quantity of eggs produced during treatment than for predicting egg quality, pregnancy, or live birth.
Provides an estimate of the number of eggs remaining in your ovaries relative to your current age.
Helps predict whether your ovaries may have a lower, expected, or higher response to fertility medications.
Helps estimate how many eggs may be retrieved during an IVF or egg freezing cycle.
Helps your physician personalize medication dosing and monitoring based on expected ovarian response.
AFC reflects estimated egg quantity, not chromosomal health or developmental potential.
AFC cannot predict exactly how many eggs will be retrieved or how many will be mature.
AFC cannot determine how many retrieved eggs will fertilize or develop into embryos.
AFC may help predict ovarian response, but it cannot predict pregnancy or live birth.
Anti-Müllerian hormone (AMH) is produced by small ovarian follicles. Because of this relationship, AFC and AMH often provide similar information about ovarian reserve:
The two results do not always align perfectly. Your physician will always interpret them alongside your age, Cycle Day 3 hormone levels, medical history, and any previous response to fertility medications rather than relying on either measurement alone.
Learn About AMH Testing
A baseline ultrasound with antral follicle count is often covered by insurance when ordered as part of a diagnostic fertility evaluation. Your exact coverage and out-of-pocket responsibility will depend on your individual plan.
For patients paying out of pocket, the estimated cost is $200–$400. Consultations, blood work, or other imaging included in your fertility evaluation may have separate costs.
Before testing begins, an Illume Fertility Financial Coordinator will verify your benefits and explain your anticipated financial responsibility.
Note: Price ranges are estimates only and are not a guarantee of current pricing. Actual costs may vary based on the services performed and your insurance coverage.
Schedule Your Consult Finance & Insurance FAQs
Learn about other testing that may be included in your fertility evaluation.
No. AFC counts the small follicles visible at the beginning of your cycle, but it cannot predict exactly how each follicle will develop.
During fertility treatment, some follicles may not grow enough to produce a retrievable egg. Some retrieved eggs may also be immature. AFC is best viewed as an estimate of your potential ovarian response, not a guarantee of how many mature eggs will be collected.
Source: ASRM
No. An egg must be mature, fertilize successfully, and continue developing before it becomes a transferable or freezable embryo.
As a broad estimate, around 70% of mature eggs fertilize during IVF (ASRM), and approximately half of those fertilized eggs continue developing into blastocysts. Actual results vary based on age, egg and sperm quality, diagnosis, treatment protocol, and laboratory factors.
Learn more by reading IVF Attrition Rate & Embryo Survival: What to Expect.
No. AFC estimates the number of small follicles present, so it primarily provides information about egg quantity and expected ovarian response—not egg quality, chromosomal health, or developmental potential.
Age remains an important factor when evaluating reproductive potential. A higher AFC does not guarantee healthy eggs or embryos, and a lower AFC does not automatically mean the available eggs are poor quality.
Current ESHRE guidance recommends AFC as a tool for predicting ovarian response rather than pregnancy or live-birth outcomes.
There is no set number. One mature egg can potentially become an embryo, but normal attrition always occurs between egg retrieval, maturity, fertilization, embryo development, and implantation.
Having more mature eggs generally provides more opportunities to create embryos, but egg quantity alone cannot predict IVF success. Your age, egg and sperm quality, embryo development, medical history, and other individual factors all influence your outcome.
There is no proven treatment, supplement, or lifestyle change that will create new eggs or permanently increase your true ovarian reserve.
However, prolonged hormonal contraception can temporarily suppress AFC and AMH in some patients. Under your physician’s guidance, stopping hormonal contraception for 2–3 months may provide a more accurate baseline measurement. This allows existing follicles to become more visible; it does not create additional eggs.
Physicians often recommend the use of hormonal contraception in preparation for a fertility treatment cycle. Follow their guidance and don't stop taking any medications without first consulting a licensed healthcare provider.
Source: ASRM
Yes. Some cycle-to-cycle variation is normal, so your AFC may not be exactly the same each month. Differences can also result from how clearly the follicles are visible and who performs the ultrasound.
Your physician will interpret the result alongside your AMH level, age, medical history, and previous test or treatment results. An unexpected AFC may sometimes be repeated in another cycle.
No. A lower AFC may suggest diminished ovarian reserve or a lower response to fertility medications, but it does not mean pregnancy is impossible.
Ovarian reserve testing is not a reliable standalone predictor of natural conception, IVF pregnancy, or live birth. Your age, egg quality, sperm health, reproductive anatomy, medical diagnosis, and treatment plan also matter.
At Illume Fertility, your AFC is reviewed by an experienced fertility specialist as part of a complete diagnostic evaluation.
We look at the full picture—including hormone levels, ultrasounds, age, medical history, and goals—to explain what your results may mean and what options will give you the highest chances of success.
If you want clear answers, a tailored plan, and support from a team that can coordinate your testing, treatment, financial guidance, and wellness resources in one place, we're here to help.
Schedule Your Consult Download Testing Workbook